These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25707916)

  • 1. The role of antibody in enhancing dengue virus infection.
    Nikin-Beers R; Ciupe SM
    Math Biosci; 2015 May; 263():83-92. PubMed ID: 25707916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotype-specific and cross-reactive neutralizing antibody responses in cynomolgus monkeys after infection with multiple dengue virus serotypes.
    Ito M; Katakai Y; Ono F; Akari H; Mukai RZ; Takasaki T; Kotaki A; Kurane I
    Arch Virol; 2011 Jun; 156(6):1073-7. PubMed ID: 21409446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection.
    Sasaki T; Setthapramote C; Kurosu T; Nishimura M; Asai A; Omokoko MD; Pipattanaboon C; Pitaksajjakul P; Limkittikul K; Subchareon A; Chaichana P; Okabayashi T; Hirai I; Leaungwutiwong P; Misaki R; Fujiyama K; Ono K; Okuno Y; Ramasoota P; Ikuta K
    Antiviral Res; 2013 Jun; 98(3):423-31. PubMed ID: 23545366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling the Relationship Between Antibody-Dependent Enhancement and Disease Severity in Secondary Dengue Infection.
    de A Camargo F; Adimy M; Esteva L; Métayer C; Ferreira CP
    Bull Math Biol; 2021 Jun; 83(8):85. PubMed ID: 34142264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can we find a possible structural explanation for antibody-dependent enhancement of dengue virus infection resulting in hemorrhagic fever?
    Mikita CP; Padlan EA
    Med Hypotheses; 2016 Mar; 88():49-52. PubMed ID: 26880637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dengue virus infection-enhancing activity of undiluted sera obtained from patients with secondary dengue virus infection.
    Moi ML; Takasaki T; Saijo M; Kurane I
    Trans R Soc Trop Med Hyg; 2013 Jan; 107(1):51-8. PubMed ID: 23296697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infection severity across scales in multi-strain immuno-epidemiological Dengue model structured by host antibody level.
    Gulbudak H; Browne CJ
    J Math Biol; 2020 May; 80(6):1803-1843. PubMed ID: 32157381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling original antigenic sin in dengue viral infection.
    Nikin-Beers R; Ciupe SM
    Math Med Biol; 2018 Jun; 35(2):257-272. PubMed ID: 28339786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopathological mechanisms in dengue and dengue hemorrhagic fever.
    Green S; Rothman A
    Curr Opin Infect Dis; 2006 Oct; 19(5):429-36. PubMed ID: 16940865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dengue virus infection-enhancing and neutralizing antibody balance in children of the Philippines and Indonesia.
    Yamanaka A; Tabuchi Y; Mulyatno KC; Susilowati H; Hendrianto E; Soegijanto S; Konishi E
    Microbes Infect; 2012 Nov; 14(13):1152-9. PubMed ID: 22841680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradoxical role of antibodies in dengue virus infections: considerations for prophylactic vaccine development.
    Acosta EG; Bartenschlager R
    Expert Rev Vaccines; 2016; 15(4):467-82. PubMed ID: 26577689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection.
    Guzman MG; Alvarez M; Halstead SB
    Arch Virol; 2013 Jul; 158(7):1445-59. PubMed ID: 23471635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fc gamma receptors.
    Mady BJ; Erbe DV; Kurane I; Fanger MW; Ennis FA
    J Immunol; 1991 Nov; 147(9):3139-44. PubMed ID: 1680925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct and indirect interactions in the recognition between a cross-neutralizing antibody and the four serotypes of dengue virus.
    Lisova O; Belkadi L; Bedouelle H
    J Mol Recognit; 2014 Apr; 27(4):205-14. PubMed ID: 24591178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand.
    Endy TP; Nisalak A; Chunsuttitwat S; Vaughn DW; Green S; Ennis FA; Rothman AL; Libraty DH
    J Infect Dis; 2004 Mar; 189(6):990-1000. PubMed ID: 14999601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The serotype-independent but concentration-dependent enhancing antibodies among Thai dengue patients.
    Teerasut C; Lei HY; Natthakorn K; Jittmittraphap A; Thammapalo S; Witayathawornwong P; Lin YT; Jarman RG; Sawanpanyalert P; Jampangern W; Limkittikul K
    Southeast Asian J Trop Med Public Health; 2012 May; 43(3):624-33. PubMed ID: 23077841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of single-round infectious, chimeric dengue type 1 virus as an antigen for dengue functional antibody assays.
    Yamanaka A; Suzuki R; Konishi E
    Vaccine; 2014 Jul; 32(34):4289-95. PubMed ID: 24950360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of humoral and cellular immune responses in cynomolgus macaques upon primary and subsequent heterologous infections with dengue viruses.
    Koraka P; Benton S; van Amerongen G; Stittelaar KJ; Osterhaus AD
    Microbes Infect; 2007 Jul; 9(8):940-6. PubMed ID: 17544804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human monoclonal antibodies to neutralize all dengue virus serotypes using lymphocytes from patients at acute phase of the secondary infection.
    Setthapramote C; Sasaki T; Puiprom O; Limkittikul K; Pitaksajjakul P; Pipattanaboon C; Sasayama M; Leuangwutiwong P; Phumratanaprapin W; Chamnachanan S; Kusolsuk T; Jittmittraphap A; Asai A; Arias JF; Hirai I; Kuhara M; Okuno Y; Kurosu T; Ramasoota P; Ikuta K
    Biochem Biophys Res Commun; 2012 Jul; 423(4):867-72. PubMed ID: 22713454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever.
    Fink J; Gu F; Vasudevan SG
    Rev Med Virol; 2006; 16(4):263-75. PubMed ID: 16791836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.